Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Gilead Sciences' Kite Pharma Deal Has Already Paid for Itself -- for Investors

TheMotleyFool

0 0

Gilead Sciences' Kite Pharma Deal Has Already Paid for Itself -- for Investors

The year 2021 -- that's when Gilead Sciences (NASDAQ: GILD) thinks its acquisition of Kite Pharma (NASDAQ: KITE) will start to pay off. When Gilead announced plans to buy Kite, the company stated that the deal was expected to be neutral to earnings by year three and accretive after that.

In one sense, though, Gilead's Kite Pharma acquisition has already paid for itself. How? For investors.

Image source: Getty Images.

Source: Fool.com